Healthcare AI company offers hands-on support to help secure funds for virtual care
SAN FRANCISCO–(BUSINESS WIRE)–GYANT, the patient connection and relationship management company, today announced a program to support hospitals and health systems as they apply for funds under the Coronavirus Aid, Relief, and Economic Security (CARES) Act. GYANT is helping customers understand what the CARES Act means for them, the application criteria, process and more, in order to boost their chances of securing funding.
Under the CARES Act, the Federal Communications Commission (FCC) has earmarked $200 million to support hospitals’ efforts to adopt telecommunications and virtual care to help manage the strain on hospitals nationwide and encourage patients to seek care from their homes versus a physical care setting. The CARES Act support is available to GYANT customers (and prospective customers) implementing the company’s telehealth solution, which offers patients chat-based patient engagement and direct transfer to a virtual care provider for evaluation. GYANT customers will be able to access professional federally-certified grant management specialists to manage the grant submission process.
“Our country’s healthcare system is navigating an unprecedented time. People are fearful and seeking information and care yet instructed to stay in their homes. Telemedicine options must step in and fill this gap,” said Stefan Behrens, CEO of GYANT. “Patient education and virtual care tools are imperative in combatting the spread of this global virus and reduce strain on hospitals and health systems. Helping our customers understand what the CARES Act will mean for their day-to-day operations, staff and the patients they serve during this time is a priority for GYANT as we continue to do our part in managing this global health crisis.”
The value and impact of virtual care has been realized as technology that can make a tremendous impact on managing the spread of COVID-19. GYANT’s COVID-19 Screener and Emergency Response Solution (COVID-19 SERA) has been adopted by multiple hospitals and health systems, including Intermountain Healthcare and OSF Healthcare. At Intermountain, the tool has engaged more than 157,000 patients about COVID-19 with a 93% screening completion rate, reducing call center volume by 30%. Additionally, OSF HealthCare experienced 14,000 interactions with the COVID-19 solution in its first two days of deployment, and 85% of patients reported a positive experience. Blue Shield of California is also offering the COVID-19 solution to in-network hospitals to manage patient volumes and efficiently connect with patients virtually.
For more information, write to the GYANT team at covid-19@gyant.com.
About GYANT
GYANT, the healthcare virtual assistant company, creates on-demand healthcare navigation software that improves care utilization while reducing administrative burden. GYANT software appears on a hospital system’s website or mobile app to chat with patients and guide them to the care and digital health tools they need, 24-7. GYANT’s virtual assistant is customizable to any organization’s branding, EHR, digital tools and clinical endpoints. GYANT ties together all of the digital tools a health system needs in a single interface, creating a seamless patient experience — increasing engagement, trust and loyalty at each stage of the healthcare journey. GYANT’s unique combination of deep intelligence, physician oversight and a human-driven, empathetic approach allows health systems to solve for traditional complex care issues, ensuring that patients receive the right care, anytime and anywhere.
Contacts
Lauren Winer
lwiner@pancomm.com
415-544-7210
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…